Dozens of states are suing to block 23andMe's sale of personal genetic data, citing concerns over customer consent and ...

After nearly 25 years with Sanofi, Sanjay Gurunathan, M.D., has left for GSK, where he will lead vaccine and infectious ...

The University of Waterloo’s School of Pharmacy announced Friday a partnership with multinational biopharma company ...

Volunteers from GSK helped to paint the garden furniture and fences at Elmhurst to improve the experience for residents at ...

GlaxoSmithKline purchased Corixa, a biotech company with offices in South San Francisco, Seattle and Hamilton, for about $300 million. No details were available over the weekend about potential ...

The 12-year-old company had been collaborating with British pharmaceutical giant GlaxoSmithKline on an immuno-oncology drug ...

These mutated diseases defy the power of antibiotics. Are illnesses really mutating so fast that we can’t stay ahead of them?

With that, Theravance expects its lifetime value from the inhaler to come out to $1.52 billion. The drug stems from a 2002 ...

Since the European Medicines Agency (EMA) approval of omalizumab in 2005 as the first ever biologic for severe asthma, the ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...